Sugammadex Versus Neostigmine Use in Patients Undergoing Septoplasty Operations

Condition(s) targeted: Nasal Septum Deviation

Phase: N/A

Status: Completed

Sponsored by: Ankara University

Official(s) and/or principal investigator(s):
CIGDEM YILDIRIM GUCLU, MD, Principal Investigator, Affiliation: ANKARA UNIVERSITY FACULTY OF MEDICINE

The purpose of this study to determine the effectiveness of sugammadex in septoplasty patients whose mask ventilation would be difficult after extubation.

Official title: Phase IV Study of the Use of Sugammadex Versus Neostigmine in Septoplasty Operations

Study design: Observational Model: Case Control, Time Perspective: Prospective

Primary outcome: easy mask ventilation for septoplasty patients

Secondary outcome: Quick and safe transfer from postoperative care unit

Detailed description: Patients undergoing septoplasty operation will be included to this study. After coming to operation room all the patients will have standard monitorisation and induction. After intubation they will have inhalational anesthesia as maintenance. According to the TOF (train of four) measurement all patient will have neuromuscular relaxant if needed. After the operation they will be extubated according to TOF or clinical parameters. And time for extubation, mask assistance need, any complication, mask difficulty, and time spent in postoperative care unit will be recorded. Then the results will be compared, whether sugammadex or neostigmine is better for these patients in means of extubation and postoperative status.

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria: ASA (American Society of Anesthesiologist) I-II patients undergoing septoplasty operation Exclusion Criteria:

- patient refusal

- any allergy to any medication used

Ankara University, Ankara 06550, Turkey

Starting date: January 2012
Last updated: January 1, 2014